Mikhail Lebedev

Mikhail Lebedev

Auto-generated profile, based on publicly available information

Mikhail Lebedev

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in Nature
Verified
Journal Article
Open access
PDF file
FRFlorian A. Rosenberger
Florian A. Rosenberger
SMSophia C. Mädler
Sophia C. Mädler
KTKatrine Holtz Thorhauge
Katrine Holtz Thorhauge
SSSophia Steigerwald
Sophia Steigerwald
MFMalin Fromme
Malin Fromme
MMMatthias Mann
Matthias Mann
Protein misfolding diseases, including α1-antitrypsin deficiency (AATD), pose substantial health challenges, with their cellular progression still poorly understood1–3. We use spatial proteomics by mass spectrometry and machine learning to map AATD in human liver tissue. Combining Deep Visual Proteomics (DVP) with single-cell analysis4,5, we probe intact patient biopsies to resolve molecular events during hepatocyte stress in pseudotime across fibrosis stages. We achieve proteome depth of up to 4,300 proteins from one-third of a single cell in formalin-fixed, paraffin-embedded tissue. This dataset reveals a potentially clinically actionable peroxisomal upregulation that precedes the canonical unfolded protein response. Our single-cell proteomics data show α1-antitrypsin accumulation is largely cell-intrinsic, with minimal stress propagation between hepatocytes. We integrated proteomic data with artificial intelligence-guided image-based phenotyping across several disease stages, revealing a late-stage hepatocyte phenotype characterized by globular protein aggregates and distinct proteomic signatures, notably including elevated TNFSF10 (also known as TRAIL) amounts. This phenotype may represent a critical disease progression stage. Our study offers new insights into AATD pathogenesis and introduces a powerful methodology for high-resolution, in situ proteomic analysis of complex tissues. This approach holds potential to unravel molecular mechanisms in various protein misfolding disorders, setting a new standard for understanding disease progression at the single-cell level in human tissue.

21 October 2025 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
GWGeorg Wallmann
Georg Wallmann
PSPatricia Skowronek
Patricia Skowronek
VBVincenth Brennsteiner
Vincenth Brennsteiner
MLMikhail Lebedev
Mikhail Lebedev
MTMarvin Thielert
Marvin Thielert
MMMatthias Mann
Matthias Mann
The scale of data generated for mass-spectrometry-based proteomics and modern acquisition strategies poses a challenge to bioinformatic analysis. Search engines need to make optimal use of the data for biological discoveries while remaining statistically rigorous, transparent and performant. Here we present alphaDIA, a modular open-source search framework for data-independent acquisition (DIA) proteomics. We developed a feature-free identification algorithm that performs machine learning directly on the raw signal and is particularly suited for detecting patterns in data produced by time-of-flight instruments. Benchmarking demonstrates competitive identification and quantification performance. While the method supports empirical spectral libraries, we propose a search strategy named DIA transfer learning that uses fully predicted libraries. This entails continuously optimizing a deep neural network for predicting machine-specific and experiment-specific properties, enabling the generic DIA analysis of any post-translational modification. AlphaDIA provides a high performance and accessible framework running locally or in the cloud, opening DIA analysis to the community.

11 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
PTPeter V. Treit
Peter V. Treit
FRFlorian A. Rosenberger
Florian A. Rosenberger
PHPhilip Hartout
Philip Hartout
MLMikhail Lebedev
Mikhail Lebedev
JXJinqiu Xiao
Jinqiu Xiao
MMMatthias Mann
Matthias Mann
Metaproteomics analyses require protein sequence databases, yet the microbial proteins present in complex communities are not known in advance. Searching reference catalogs containing hundreds of millions of candidate sequences reduces identification sensitivity, while generating sample-specific databases through metagenomic sequencing adds time and cost. We introduce FastaLake, a computational workflow that uses full-length de novo peptide predictions by AlphaNovo to retrieve complete proteins from broad sequence resources and selects compact databases for conventional searching. In a defined eight-member community, FastaLake approached reference-search peptide yields without knowing its members. Using public sequence catalogs, FastaLake identified about as many peptides as matched metagenomic databases in two stool cohorts and 20–35% more in intestinal fluid at the same nominal 1% peptide false discovery rate. The resulting proteomes reveal personal functional profiles that persist across intestinal regions despite differences in leading species between intestinal fluid and stool. DNA, RNA and protein profiles agreed on broad differences between patients but only weakly on individual functions. All 726 acquisition-specific databases were smaller than the human reference proteome. Compact databases allowed non-specific searches of all 347 CapScan acquisitions, revealing histidine enrichment at peptide C termini in intestinal fluid. FastaLake enables metaproteomics analysis without matched metagenomic sequencing by constructing search databases from sequence resources and de novo peptide sequencing.